Cancer Therapy News and Research

RSS

Findings may yield novel therapeutic strategies for late-stage breast cancer

Researchers from the Boston University School of Medicine (BUSM) have determined how the TGFβ-Smad signaling pathway, which is over activated in late-stage cancers, is responsible for the "epigenetic memory" that maintains unique patterns of regulatory DNA hypermethylation causing silencing of critical genes that facilitate breast cancer progression.

25 Jan 2010

New online resource to help people with Oral Mucositis launched

From today, a new resource is available to help people with Oral Mucositis: http://www.mouthsmadegood.com. Oral Mucositis (OM) is a side effect of cancer therapy and is characterised by a red, swollen and ulcerated mouth and tongue.

25 Jan 2010

ACS Chemical Biology report supports zebrafish for drug development

By combining the tools of medicinal chemistry and zebrafish biology, a team of Vanderbilt investigators has identified compounds that may offer therapeutic leads for bone-related diseases and cancer.

22 Jan 2010

Research shows frozen human eggs are as effective as fresh eggs to preserve fertility

Fertility specialists responsible for the first pregnancy in the Pacific Northwest resulting from frozen human eggs are hailing new research showing that frozen eggs can be as effective as fresh eggs in helping previously infertile women achieve pregnancy.

22 Jan 2010

Cancer Research UK offers translation service for people affected by cancer

Thanks to a partnership with Language Line - who interpret telephone conversations in over 170 languages - people affected by cancer who need an interpreter can now have their questions answered.

21 Jan 2010

Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tablets

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis’ breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva’s Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.

21 Jan 2010

Research provides new insights on VEGF receptor function

Researchers at the University of Helsinki, Finland, and the Paul Scherrer Institute (PSI) in Villigen, Switzerland, have determined the crystal structure of the ligand binding domain of a vascular endothelial growth factor (VEGF) receptor in complex with one of its ligands (VEGF-C).

21 Jan 2010

First Coast Oncology uses PEM scanner and AccuBoost image guided procedure for breast cancer treatment

First Coast Oncology in Jacksonville, Florida has significantly enhanced its ability to treat breast cancer with the addition of a Naviscan PEM (Positron Emission Mammography) scanner.

20 Jan 2010

Modern healthcare in Tri-Cities offers bright economic future and improved quality of life

Reliable, modern healthcare is Tri-Cities, Tennessee's "ace in the hole" when it comes to future economic development and improved quality of life.

20 Jan 2010

Health Canada approves Novartis' Afinitor to treat patients with mRCC

Novartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).

20 Jan 2010

Navigating Cancer announces the launch of new, free website for cancer patients

Navigating Cancer announced today the public beta launch of its new, free website specifically for cancer patients, www.navigatingcancer.com. Navigating Cancer provides essential cancer-related information from authoritative sources to help patients learn about their options once diagnosed, and tools for patients to partner with their physicians, allowing them to be more in control of their cancer treatment and care.

20 Jan 2010

GEH, Exelon Generation agree to a landmark deal to deploy GEH’s isotope generation technology

Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal to deploy GEH’s isotope generation technology.

20 Jan 2010

Social factors still influence access to cancer services

People who develop the most common forms of cancer are still more likely to be diagnosed at a late stage in their disease if they live in a deprived area, new research has found.

19 Jan 2010

Blocking release of VEGFs may inhibit tumor growth

19 Jan 2010

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

AstraZeneca and Dako Denmark A/S announced today that they have entered into a collaboration agreement to develop companion diagnostic tests for multiple AstraZeneca oncology projects, including biologics and small molecules, in various stages of discovery and development.

18 Jan 2010

Medical professionals and breast cancer survivors to attend 10th international conference in Georgia

2010 marks the 10th anniversary of the only international conference dedicated to the critical issues of young breast cancer survivors and those who care about them.

18 Jan 2010

Treatment for metastatic tumor based on its unique protein makeup

Imagine if treatments for disease could be based not on a patient's diagnosis but instead on the characteristics of their tissue. By identifying and decoding the cryptic messages hidden deep inside the human proteome, scientists and physicians who study personalized medicine are seeking more effective treatments and disease management for patients.

18 Jan 2010

Bone marrow transplantation survivors can father children: new study says

Men who were previously deemed sterile due to aggressive cancer treatments may still be able to biologically father children according to a new study published in the journal, Bone Marrow Transplantation.

18 Jan 2010

Work provides new insight into potential therapeutic treatments for cancer diseases

An enzyme that normally helps break down stored fats goes into overdrive in some cancer cells, making them more malignant, according to new findings by a team at The Scripps Research Institute.

13 Jan 2010

Theragenics signs agreement with Core Oncology for distribution of TheraSeed palladium-103 brachytherapy seeds

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Core Oncology, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds.

13 Jan 2010

Cancer Therapy News and Research

Findings may yield novel therapeutic strategies for late-stage breast cancer

New online resource to help people with Oral Mucositis launched

ACS Chemical Biology report supports zebrafish for drug development

Research shows frozen human eggs are as effective as fresh eggs to preserve fertility

Cancer Research UK offers translation service for people affected by cancer

Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tablets

Research provides new insights on VEGF receptor function

First Coast Oncology uses PEM scanner and AccuBoost image guided procedure for breast cancer treatment

Modern healthcare in Tri-Cities offers bright economic future and improved quality of life

Health Canada approves Novartis' Afinitor to treat patients with mRCC

Navigating Cancer announces the launch of new, free website for cancer patients

GEH, Exelon Generation agree to a landmark deal to deploy GEH’s isotope generation technology

Social factors still influence access to cancer services

Blocking release of VEGFs may inhibit tumor growth

AstraZeneca and Dako Denmark A/S enter into collaboration agreement

Medical professionals and breast cancer survivors to attend 10th international conference in Georgia

Treatment for metastatic tumor based on its unique protein makeup

Bone marrow transplantation survivors can father children: new study says

Work provides new insight into potential therapeutic treatments for cancer diseases

Theragenics signs agreement with Core Oncology for distribution of TheraSeed palladium-103 brachytherapy seeds

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News